Please sign in to follow a disease.
Xvivo Perfusion
Clinical trials sponsored by Xvivo Perfusion, explained in plain language.
Medical technology for organ preservation and transplantation.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device aims to keep donor hearts healthier for transplant Results expected May 2027 (estimated)
-
New device aims to keep donor hearts healthier for transplant
Disease control Recruiting nowThis early trial tests a device that keeps donor hearts cool and oxygenated during transport, instead of the usual ice cooler. The goal is to see if this method is safe and works for heart transplants from both brain-dead and circulatory-death donors. Twenty adult patients awaiti…
Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New device could keep donor hearts alive longer for transplant
Disease control Recruiting nowThis study tests a device that keeps donor hearts functioning outside the body without stopping blood flow. It aims to safely use hearts from extended-criteria donors (e.g., older or with other health issues) for transplant. Sixty adult heart transplant recipients will receive a …
Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC